热门资讯> 正文

RadNet的DeepHealth通过TechLive获得FDA批准

2025-08-07 21:11

DeepHealth, a unit of RadNet (NASDAQ:RDNT), announced that it has received FDA clearance for TechLive, a new remote scanning solution.
TechLive is designed to work with various imaging technologies, allowing for remote scanning of MR, CT, PET/CT, and ultrasound procedures.
RDNT stock is down 24% YTD.

More on RadNet

iCAD Merger Arbitrage: Low-Risk Returns From A Game-Changing AI Imaging Acquisition
RadNet, Inc. (RDNT) Q1 2025 Earnings Call Transcript
RadNet secures $100M incremental term loan
Key deals this week: Qualcomm, Chart Industries, RadNet, AMD and more
Seeking Alpha’s Quant Rating on RadNet

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。